Antiporte, Julito F.

HRN: 23-86-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/24/2026
06/30/2026
IV
500mg
Q8
Cholecystitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines